Friday, August 12, 2016

BRIEF-Zealand Pharma: supportive results from Phase II trial of dasiglucagon

* Announced on Thursday supportive results from a Phase II trial with a single-dose version

of dasiglucagon as rescue treatment of severe hypoglycemia

Read more

No comments:

Post a Comment